Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

AMLXAMLX
Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in AMYLYX PHARMACEUTICALS INC

BANK OF AMERICA CORP /DE/ holds 821,841 shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $14.8M as of 2026-Q2. The position was decreased (-38.2% shares). AMLX represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$14.8M

Current Shares

821,841

Total Value Change

+$11.8M

Total Shares Change

-90,674

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
821,841
-38.2%
$14.8M0.0%$17.96
0
2026-Q1
Decreased
1.3M
-0.4%
$18.5M0.0%$14.11
0
2025-Q4
Increased
1.3M
+211.1%
$16.1M0.0%$12.00
45
2025-Q3
Decreased
429,516
-4.9%
$5.8M0.0%$14.90
0
2025-Q2
Decreased
451,808
-43.1%
$2.9M0.0%$6.33
0
2025-Q1
Decreased
794,354
-67.3%
$2.8M0.0%$3.66
0
2024-Q4
Increased
2.4M
+165.9%
$9.2M0.0%$3.84
45
2024-Q3
Increased
912,515
+91.1%
$3M0.0%$3.08
42

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used